Please assess the completion status of the following clinical trial:

Trial Title: Oxidative Stress Links Aging, Activity, and Mobility Limitation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy men and women aged either between 18 - 30 years (young group) and \>70 years (old group)~* Free of overt disease. Subjects will be non-obese (BMI \< 30) and have plasma glucose concentrations \< 7.0 mmol/L under fasting conditions and \< 11.1 mmol/L at 120 minutes of an oral glucose tolerance test (OGTT)~* Subjects will be sedentary, defined here as no regular physical activity for at least the prior 2 years~* Candidates must have no orthopedic limitations that would prohibit them from performing cycle or knee-extensor exercise~* All women will be postmenopausal (either natural or surgical) defined as a cessation of menses for at least 2 years, and in women without a uterus, follicle stimulating hormone (FSH) \> 40 IU/L~Exclusion Criteria:~* Candidates demonstrating dyslipidemia based on the National Cholesterol Education Program Guidelines of plasma total cholesterol \> 240 mg/dl with LDL-cholesterol \> 160 mg/dl will be excluded from participation~* Candidates who smoke or are taking medications (blood pressure medications, statins, antioxidants etc.) that could influence the results of the study will not be eligible~* In terms of diet, subjects will be asked to maintain a dietary record for one week prior to the pre-screening and if this reveals a diet that differs substantially from the typical average diet in both the young and old, the subject will not be eligible~* Women currently taking hormone replacement therapy (HRT) in the preceding year will be excluded from the proposed studies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Arm 1 (Type: OTHER): Young healthy men and women aged 18-30
- Arm 2 (Type: OTHER): Older healthy men and women aged \>70.

Based on this trial design, predict the completion outcome and termination type (if applicable).